Cerapedics Print Logo
Cerapedics - Enhancing the Science of Bone Repeair

About Us


Cerapedics is a privately held medical device company focused on developing and commercializing novel osteobiologic products based on a proprietary small peptide technology, P-15™, on Anorganic Bone Mineral (ABM).

P-15 is the key component in the i-FACTOR™ Biologic Bone Graft family of products and is ideal for use in the repair of bony voids or defects in orthopedic and spine applications.

History

The first P-15 enhanced bone graft substitute was developed for use in the oral cavity by CeraMed Dental - the precursor to Cerapedics - under the leadership of Andrew J. Tofe, Ph.D. The product received PMA approval in 1999 based on the results of two prospective multi-center investigations. It remains the only dental bone graft substitute with FDA approved claims of superiority over demineralized bone (DBM) allograft and alloplasts. Since approval, ABM/P-15 has been used in more than 500,000 cases worldwide with an exceptional safety profile.

Cerapedics is now actively involved in commercializing i-FACTOR Biologic Bone Graft in the fast-growing market for osteobiologic products.

Click here to learn more about i-FACTOR™ Putty and i-FACTOR™ Flex.